期刊文献+

细胞工厂制备冻干甲型肝炎减毒活疫苗猴体安全性和免疫原性研究 被引量:7

Safety and Immunogenicity Testing of Monkey in the Preparation of Hepatitis A(Live) Vaccine,Freeze-dried by Cell Factory
原文传递
导出
摘要 [目的]了解细胞工厂和转瓶工艺生产的冻干甲型肝炎减毒活疫苗免疫恒河猴后的安全性和免疫原性。[方法]用静脉注射的方式为恒河猴接种疫苗,观察恒河猴的临床症状、体征、生化、免疫学反应以及肝组织的病理变化。[结果]细胞工厂和转瓶工艺生产的冻干甲型肝炎减毒活疫苗均未见临床症状和体征的异常改变,ALT正常,抗-HAV在观察期内持续阳性,肝组织无病毒性肝炎的病理性改变。[结论]细胞工厂和转瓶工艺生产的冻干甲型肝炎减毒活疫苗对恒河猴的免疫效果相同,具有良好的保护作用。 [Objective]To compare safety and immunogenicity of rhesus after vaccination of Hepatitis A (Live) Vaccine,freeze-dried manufactured by cell factories and roller bottles process, i-Methods]Vaccine should be injected by intrave- nous injection,observe the clinical symptoms, signs,biochemical, immunological reactions and pathological changes of liver tissues of rhesus. [Results]No abnormal clinical signs were observed from both groups, ALT, anti-HAV antibody were persistently positive during the observation period,no viral hepatitis pathological changes on liver tissues. [Conclusion]The immune effect of manufacturing process of cell factories and roller bottles of Hepatitis A (Live) Vaccine, freeze-dried are the same,they all have good protective effect from Hepatitis A.
出处 《预防医学论坛》 2012年第7期526-527,共2页 Preventive Medicine Tribune
关键词 冻干甲型肝炎减毒活疫苗 细胞工厂 安全性 免疫原性 Hepatitis A (Live) Vaccine, Freeze-dried Cell factory Safety Immunogenicity
  • 相关文献

参考文献2

二级参考文献56

  • 1胡孟冬,孙碧芳,周艳琴,邱志芳.甲型肝炎减毒活疫苗的研究——毒株减毒与狨猴实验[J].上海医学,1988(11):653-657. 被引量:5
  • 2庄昉成,毛江森.中国控制甲型肝炎之前景[J].中国计划免疫,2004,10(3):171-173. 被引量:11
  • 3柴少爱,张杭春.甲型肝炎病毒H2减毒株的某些遗传特征[J].中华医学杂志,1993,73(6):335-337. 被引量:4
  • 4毛江森 谢汝英 等.甲型肝炎减毒活疫苗的研究1.不同毒力毒株的猴体试验[J].中国科学:B辑,1987,(6):625-630.
  • 5徐志一 赵守军 等.甲型肝炎预防效果与免疫策略[J].中华预防医学杂志,1996,30:3-5.
  • 6Winokur PL,McLinden JH,Stepleton JT,et al.The hepatitis A virus polyprotein expressed by a recombinant vaccinia virus undergoes proteolytic processing and assembly into virus-like particles[J].J Virol,1991,65:5028-5036.
  • 7Karayiannis P,O'Rourke S,McGarvey MJ,et al.A recombinant vaccinia virus expressing hepatitis A virus structural polyprides:characterization and demonstration of protective immunogencity[J].J Gen Virol,1991,72:2167-2172.
  • 8Rosemarie Berger,Max just,Beat Althaus.Time course of hepatitis A antibody production after active,passive and active/passive immunization:the results are highly dependent on the antibody test system usedf[J].J Viro Methods,1993,43:287-298.
  • 9Wedermann G,Ambrosch F,Andre F,et al.Persistence of vaccine induced antibody to hepatitis A virus[J].Vaccine,1992,10(Supp1):S129-131.
  • 10Medithun K,Ellerbeck E,Gershman K,et al.Safety angimmunogencity of a live attenuated hepatitis A virus vaccine in seronegative volunteers[J].J Infect Dis,1991,163:735-739.

共引文献9

同被引文献60

  • 1陈统球,钟光六,阳选祥,曹逸云.在人二倍体细胞上分离和适应的甲型肝炎病毒株[J].中国医学科学院学报,1996,18(1):29-32. 被引量:8
  • 2陈志慧,王宪明,殷月娣,王亮,沈谊清,徐建军,吕国贞,王树巧.水痘减毒活疫苗的研制及免疫效果观察[J].国际生物制品学杂志,2006,29(3):97-100. 被引量:31
  • 3疫苗流通和预防接种管理条例[s].2005.
  • 4TAKAHASHI M,ASANO Y,KAMIYA H. Development of vari- cella vaccine [ J ]. J Infect Dis,2008 ( Suppl 2 ) : S41 - S44.
  • 5GERSHON AA,KATZ SL. Perspective on live varicella vaccine [ J]. J Infect Dis ,2008 ( Suppl 2 ) : S242 - S245.
  • 6赵凯;章以浩;李河民.医学生物制品学[M]北京:人民卫生出版社,2007.
  • 7Berger TG,Feuerstein B,Strasser E. Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories[J].{H}Journal of Immunological Methods,2002,(02):131-140.
  • 8Tuyaerts S,Noppe SM,Corthals J. Generation of large num-bers of dendritic cells in a closed system using cell factories[J].{H}Journal of Immunological Methods,2002,(1/2):135-151.
  • 9Suzuki M,Cela R,Clarke C. Large-scale production of high-quality helper-dependent adenoviral vectors using adherent cells in cell factories[J].{H}Human Gene Therapy,2010,(01):120-126.
  • 10Nalin DR. VAQTA, hepatitis A vaccine,purified inactivated [J]. Drugs of the Future,1995,20:24-29.

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部